ERBB2 and breast carcinoma: These therapies encompass chemotherapy, radiotherapy, endocrine therapy (for cancers expressing female sex hormone receptors), targeted therapy (predominantly in cases of HER2-positive breast cancer) and more recently immunotherapy, all with varying degree of toxicity, some of which can be even life-compromising.